Switching to another patch

Two patches with the same number on the box deliver the same amount of estradiol a day. What changes from one brand to the next is how often you change it, how big it is, and how it sticks.

Three families of US patches

FamilyChangedProducts0.05 mg size
Climara typeOnce a weekClimara, Sandoz, Mylan and Zydus weekly generics12.5 to 15.5 cm²
Vivelle-Dot typeTwice a weekVivelle-Dot, Sandoz, Mylan and Zydus twice-weekly generics, Dotti3.78 to 5.4 cm²
Minivelle typeTwice a weekMinivelle (brand discontinued), Noven unbranded, Mylan, Lyllana3.3 to 5.0 cm²

Sizes from each product's label on DailyMed; the FDA's ratings from the Orange Book.

Within a family, the FDA rates the generics as equivalent to the brand. Between families the strength is the same, but the patches are different products: a weekly patch holds a week's estradiol in a larger patch, a twice-weekly one holds 3 to 4 days' worth in a smaller one. In Canada, Estradot and Sandoz Estradiol Derm are twice-weekly and Climara is weekly.

What the labels say

  • Vivelle-Dot's label says it can be started at once "in a woman switching from another estradiol transdermal therapy" (Vivelle-Dot label).
  • Climara's label says to wear only one patch at a time during the 7 days (Climara label).
  • If a weekly patch falls off and can't be put back, the Climara label says to put on a new one for the rest of that week; the twice-weekly labels say to carry on with the original schedule.
  • None of the patch labels mentions cutting a patch. ASHP warns that cutting one "may result in uneven dose release" (ASHP).

How and when to switch is your prescriber's or pharmacist's call, especially between a weekly and a twice-weekly patch.

What doctors have told the press

Dr JoAnn Pinkerton of UVA Health, a past president of The Menopause Society, told AARP that patients can use "a different brand of a twice-a-week patch or a once-a-week patch for a short interim". Dr Lauren Streicher of Northwestern said most people given a reasonably equivalent dose "are not going to notice the difference", while some may get less estrogen and should raise it with their prescriber (AARP).

Cost when you switch

A different brand may sit on a different tier of your plan's formulary. If a shortage forces you onto one that isn't preferred, ask your prescriber about a coverage exception before you pay the difference.

Sources

  1. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (data files), FDA, October 9, 2026.
  2. Vivelle-Dot label, DailyMed, Sandoz, November 17, 2023.
  3. Climara (estradiol transdermal system) label, DailyMed, Bayer, March 26, 2026.
  4. Minivelle label, DailyMed, Noven, July 31, 2026.
  5. Dotti label, DailyMed, Amneal, May 14, 2024.
  6. Drug Shortage Detail: Estradiol Transdermal System, ASHP, August 12, 2026.
  7. What to do during the estrogen patch shortage, AARP, March 13, 2026.